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Abstract
Background: We investigated the physicochemical properties of Medifoam® N and its wound healing performance
compared to other commercially available polyurethane (PU) foam dressing in vitro and in vivo to gain insight in
their clinical performance.
Methods: Wound contact layer and cross-section of eleven polyurethane foam dressings were assessed with
field-emission scanning electron microscope. Thickness, density, tensile strength, elongation, moisture-vapor transmission
rate (MVTR), retention and absorptivity were measured to compare physical properties. Phosphate-buffered saline (PBS)
solution absorption patterns were compared. An animal model for wound-healing was applied to validate in vitro findings.
Results: Among eleven tested foam dressings, Medifoam® N has the smallest pore and cell sizes with excellent uniformity,
i.e. it has 25 ~ 75 μm on the wound contact layer and 100 ~ 350 μm in the cross-section while other dressings have a
larger pose size with larger variability. Compared to other PU foams, Medifoam® N also has moderate thickness, density,
tensile strength, elongation and MVTR. Furthermore, it has excellent fluid absorption and retention capacity. These intrinsic
properties of Medifoam® N contributed to improve fluid absorption patterns, i.e. other dressing material flawed out PBS
solution on the dressings while Medifoam® N retained all the tested solutions. In animal wound-healing study, Medifoam®
N treated animals showed excellent angiogenesis and collagen deposition even though epithelial recovery rate was not
significantly different to other dressings.
Conclusions: Medifoam® N has optimized physical properties and thus improved fluid absorption/retention capacity.
Compared to other dressings, Medifoam® N showed excellent fluid absorption patterns and these characteristics
contributed to improved wound healing and excellent angiogenic potential. We found that Medifoam® N showed the
best results among the employed dressing samples.
Keywords: Wound healing, Porosity, Foam dressing, Absorption/retention capacity, Absorption pattern,
Moisture-vapor transmission rate
Background
Key objectives in wound healing are the reduction of in-
fection and pain as well as the promotion of tissue repair
[1–3]. Various kinds of materials have been used to this
purpose. In ancient times, natural materials including
honey pastes, plant or animal materials, and cloth have
been used for wound healing purposes [1, 2, 4]. In the
last several decades, novel materials using synthetic bio-
compatible polymers and natural polymers have been
developed to improve the wound healing performance
[4–8]. Natural polymers such as chitin and chitosan have
been extensively investigated since they have adhesive
properties, antifungal/antibacterial characters, and oxygen
permeability [6]. Synthetic polymers were also investigated
for wound healing purposes [4, 6, 7]. For example,
polypeptide-poly(ethylene glycol) block copolymer was re-
ported to have suitable properties for wound healing with
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suppression of bacterial proliferation, granulous tissue
formation and wound contraction [7].
In other words, physical properties of wound heal-
ing materials play a key role in creating an environ-
ment conductive to wound healing [4]. Junker et al.,
reported the importance of the microenvironment to
wound healing [9]. They emphasized that a wet,
incubator-like microenvironment is important to
provide the fastest healing with fewest aberrations
and least scar formation. Bilayered polyurethane
wound dressing composed of microporous top layer
and highly porous sponge-like sublayer are known to
provide efficacy in the prevention of dehydration,
bacterial penetration, and bullae formation [8]. Fur-
thermore, Doillon reported the importance of porous
structure on the wound tissue infiltration in vivo as
well as cell growth in vitro [10]. The goal in select-
ing a suitable dressing is to create an optimal envir-
onment that best facilitates healing by providing
protection from contamination and infection, enhan-
cing the activity of enzymatic and cellular systems to
promote re-epithelialization, and controlling the bio-
mechanics of the wound area to provide mechanical
stability [3, 11–13]. The use of inappropriate wound
dressings can contribute to the development of
infection or the formation of excessive scar tissue,
which significantly undermines a proper healing
process [3, 13]. Furthermore, exudate containment is
regarded to an importance factor in the quality-of-
life problems since excessive exudate leads to mal-
odor and leakage resulting in loss of sleep, depres-
sion, and social isolation in affected patients [14].
In this study, we performed a wide range of labora-
tory tests using various commercially available dress-
ings to evaluate their physical and morphological
characteristics with respect to potential wound heal-
ing properties. This physicochemical testing may pro-
vide insight into the performance of medical devices,
which essentially perform on physical, not pharmaco-
logical, metabolic or immunological modes of action.
The relationship between physicochemical properties
and biological/pathological performance of dressings
was of particular interest. Additionally, an animal
wound healing model was used to evaluate actual
wound healing comparing traditional gauze dressing
and various polyurethane foam dressings.
Methods
Materials
Medifoam® N was obtained from Genewel Co. Korea.
Dressing A, B, A1, L, P, S, C, F, T, M, P1 were pur-
chased from Allevyn (Smith & Nephew Co.), Biatain
(Coloplast Co.), Askina (Braun Co.), Lyofoam Extra
(ConvaTec Co.), Permafoam (Paul Hartmann Co.),
Suprasorb (Lohmann & Rauscher Co. Ltd.), Cellosorb
Adhesive (Urgo Medical Co.), Foam-S. (3 M Co.),
Tegaderm (3 M Co.), Mepilex (Mölnlycke Health
Care Co.), and Polymem (Ferris Manufacturing Co.),
respectively. PBS (pH 7.4, 0.01 M) with pigment
(SCU656, 0.1 %, DaeBo Co. ltd, Gyeonggi-do, Korea)
was purchased from Gibco (NY, USA). All organic
solvents were used as extra pure grade without fur-
ther purification (Scheme 1).
Scheme 1 Pore size measurement from FE-SEM observation
Lee et al. Biomaterials Research  (2016) 20:15 Page 2 of 11
Morphology observation
Morphology of each dressing was assessed with field-
emission scanning electron microscope (FE-SEM, S-4800,
Hitachi, Tokyo, Japan). For FE-SEM testing, each dressing
was cut into uniform size and then coated by platinum
coater. Observation was performed at 25 kV. In the
morphology analysis, the pore size and pore size uniform-
ity of each dressing were measured and compared.
Thickness and density measurements
Dressing thickness was measured with MDH microm-
eter high accuracy sub-micron digimatic micrometer
(CD-15CPX, Mitutoyo Co. Ltd., Kawasaki, Japan). Thick-
ness was measured at least 10 times with different sam-
ples and then expressed as average ± standard deviation.
For density measurement, width and length of each
dressing was measured and then density was calculated as
follows: Density(g/cm3) = weight/width × length × thickness.
Density of each dressing were measured at least 10 times
with different samples and then expressed as average ±
standard deviation.
Physical properties of dressings
All physical properties of dressings were estimated
performed according to the methods described in
American Society for Testing and Material (ASTM)
or European Norm (EN) [15–17].
Moisture vapor transmission rate (MVTR)
The method for evaluation of MVTR was used the re-
ported method by Khan et al., [5] with slight modifica-
tion. Aluminum cup (diameter: 62 mm, absorptive area:
28 cm2) were pretreated in a dry oven (100 °C) 2 h prior
to testing. Then, 20 g CaCl2 was put into this aluminum
cup and then each dressing tied onto the top of the
aluminum cup. 10 glass bottles were used for each dress-
ing. 2 h prior to test, paraffin was pretreated in a dry
oven (100 °C). In the aluminum cup, the specimen was
set to face CaCl2 and the dead center of the cup to cre-
ate a concentric ring. Melted paraffin was poured along
the edge of the absorptive cup (beaker) to seal the edges.
The paraffin debris around the joint cup was removed and
then initial weight of the joint cup was measured (W0).
The joint cup put into the thermo-hygrostat (37 °C, 75 %
humidity) for 24 h, after which the weight of the joint cup
was measured (W24). Then, the MVTR of the samples
were calculated as follows:
Moisture vapor transmission rate g=m2=hrs
 
¼ W24‐W0ð Þ=0:0028  B½   24 h
W0: initial weight of the sample before put into the
thermo-hygrostat
W24: weight of the sample in thermo-hygrostat for
24 h
0.0028: unit conversion of absorptive area (cm2→m2)
B: real time
Absorption rate and moisture retention capacity
Absorption rate was measured as follows: All dressings
were cut into (5 × 5) cm and weighed (W1). Excess amount
of deionized water (40 times higher than dressings, 37 ±
1 °C) was added 500 ml beaker. Temperature was con-
trolled with pyrostat (OF-21E, Jeio Tech, Daejeon, Korea)
at 37 °C for 30 min. After that, dressings were suspended
and then weighed for 30 s (W2). The absorption rate was
calculated as follows: [Absorption (g/cm2) = (W2-W1)g/
Initial area of dressing (cm2).
Retention capacity was measured as follows: Initial
weight (A) and thickness (B) of dressings were measured
to similar with absorption study. All dressings were
pressed with standard weight (111209, Jongro industrial
Co., Ltd., Seoul, Korea) by 5 kg-weigh, for 20s and then
calculated the retention weight (D) as follows: Retention
capacity (g/cm2) = D – A/Initial area of dressing (cm2).
Tensile strength
To measure tensile strength, dressings were carefully cut
into the form of Dog-bone (6 mm× 105 mm) using a
wood-molded blade. The surface was kept unscathed
when cutting. Tensile strength was measured with a ma-
terial test machine (3343Q9831, Instron Co., MA, USA).
Dressings were installed into the equipment symmetrically
across the cross-section of the grip of the instrument and
then dressings pulled out at a speed of 300 mm/min to
measure the tensile strength at snap. Tensile strength was
calculated as follows: [Tensile Strength (kgf/cm2) =MAX
Failure Strength (kgf)/Cross-section of Specimen (mm2)].
Elongation was calculated as following equation:
Elongation(%) = (D2-D1)/D1 × 100. D1: Initial Inter-
clip Distance. D2: Inter-clip Distance at Snap.
In vivo testing of wound healing
The wound healing abilities of dressings were studied
by an animal wound model using Sprague Dawley
(SD) rat (200 ~ 220 g, 8 week). All rats were freely
fed water and food during experiment and 6 rats
were used for each group. The backs of rats were
shaved and then circular wounds with 25 mm diam-
eter induced using a blade. Wounds were treated by
foam dressings and then covered with gauze to avoid
contamination, and secured with a film dressing
(polyurethane film, Opsite, Smith & Nephew, UK).
Dressings were bandaged to prevent nibbling by rats and
replaced on 2 to 3-day intervals. General symptomatic
properties, mortality rate, body weight, eating and drink-
ing habits were comprehensively observed on a daily basis.
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Epithelialization of wounds on the backs of rats was
assessed at days 3, 7, 10 and 14 by analysis of photographs.
The sizes and epidermal recovery rate of wounds were
measured based on observed photographs. At day 7, Tis-
sues were collected for evaluation of impaired skin tissues
and adapted with immunohistochemistry. All animal
study was carried out according to the guidelines of com-
mittee of Genewel Institutional Animal Care and Use
Committee (IACUC) (Ref. No: GAP-AVAL-14021).
Angiogenesis during wound closure was evaluated
as following: At day 14, tissues were collected and
dyed (hematoxylin and eosin (H&E) stain kit, American
Fig. 1 Morphological observation of surface (wound contact layer (a) and cross section (b) of dressings by FE-SEM
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MasterTech, CA, USA) to assess angiogenesis in the
newly forming skin tissue. Collagen deposition over
wound care was assessed as the level of inner skin depos-
ition and thickness were evaluated in assessment of full
recovery of the impaired skin tissue.
Results
Analysis of morphological and physical properties
To observe morphological differences, surface (wound
contact layer) and cross-section of dressings were ob-
served with FE-SEM as shown in Fig. 1. As shown in
Fig. 1a, Medifoam® N has relatively uniform and smaller
pore size compared to other dressings, i.e. surface pore
size of Medifoam® N was about 25 ~ 75 μm while pore
size of other dressings were ranged from 32 to 1000 μm
with lack of uniformity. Furthermore, cross-section of
each dressing was also observed as shown in Fig. 1b. Ex-
cept Medifoam® N, all dressings have non-homogeneous
pore sizes and morphologies and pore sizes ranged from
169 μm to 1000 μm. Medifoam® N has relatively uniform
pore size and homogenous morphology with ranged
from 100 to 350 μm. Pore size of each dressing was
summarized in Table 1.
The physical properties of Medifoam® N dressing was
compared with other commercially available foam dress-
ings. Description of methods for each of the following
analyses, including equations, will be presented below
for thickness, density, MVTR, absorption rate, moisture
retention capacity, tensile strength, elongation).
Thickness and density are shown in Fig. 2. As shown
in Fig. 2a, Medifoam® N has a medium thickness of
5.14 mm and dressing L has highest value in thickness
among all dressings. Figure 2(b) shows the density of
each dressing. Dressing P1 has the highest density
among all tested dressings and Medifoam® N has also an
excellent density (0.19 g/cm3) compared to other
dressings.
Generally, a lower value of MVTR may impede wound
healing due to poor drainage of the absorbed exudation.
Accordingly, excessively high MVTR values may give
rise to dry wound surface due to excessive loss of fluid
as water vapor. Thus, MVTR along with absorption/re-
tention capacity is one of the important characteristics
for a device to ensure moist wound healing. MVTR and
absorption/retention capacity was evaluated as shown in
Fig. 3. As shown in Fig. 3a, MVTR of Medifoam® N has a
mid-range value among the products (811 g/m2/day).
Dressing P has the highest value of MVTR and L has the
lowest value. The absorption/retention capacity of a dress-
ing is crucial in absorbing exudation and retaining post-
absorption moist condition, respectively. As shown in
Fig. 3b, absorption/retention capacity of Medifoam® N was
notably higher than other dressings, i,e, Medifoam® N has
absorption and retention capacity of 1.25 and 0.47 g/cm2,
respectively.
Tensile strength and elongation was shown in Fig. 4. As
shown in Fig. 4a, Medifoam® N has good tensile strength
(0.033 kgf mm−2) with a mid-ranged value. Dressing C has
highest tensile strength among all tested dressings. The
mean tensility of the other 8 products ranged about
0.01 kgf mm−2 ~ 0.025 kgf mm−2. As shown in Fig. 4b,
dressing M has the greatest elongation properties among
all the dressings tested (mean, 1101 %), followed by dress-
ing A1 (428 %). Medifoam® N has also good elongation
property (412 %). The remaining 8 products were ranged
around 180–377 %.
In vivo analysis of wound healing
Wound healing potential of Medifoam® N was studied using
rat wound healing model and compared with dressing A
and T as shown in Fig. 5. A visual comparison of skin recov-
ery was recorded photographically. Comparisons on wound
closure were done day by day. Until day 7, Medifoam® N
showed slightly smaller wound area than other treatment
even though it was not practically different with other treat-
ment at day 14. At Day 14, no significant difference was ob-
served with respect to evidence of inflammation and
rejection, and rate of wound healing (skin recovery). Of the
dressing tested, only gauze showed evidence of wound adhe-
sion. On Day 14, specimens from the entire groups were al-
most cured, with no materials sticking to the wound save
for gauze, evidencing effective prevention of secondary skin
impairment and pyrogenic, flaring or inflammation as rejec-
tion symptoms. For all test groups, the specimens showed
fast rate of recovery and approved that the wound dressing
materials effectively promoted wound healing.
Figure 6 shows the histopathological analysis of skin tis-
sue samples from wound healing area. As shown in Fig. 6,
initial wounded area and new generated epidermal area
was marked with arrows at Day 7. Assuming the entire
length of wound being ‘C’ and the epidermal recovery rates
Table 1 Pore size of dressings
Wound contact layer (μm) Cross-section (μm)
Medifoam® N 25 ~ 75 100 ~ 350
A 52 ~ 154 169 ~ 455
B 53 ~ 158 241 ~ 366
A1 32 ~ 214 337 ~ 726
L 22 ~ 88 456 ~ 917
P 112 ~ 423 325 ~ 421
S 75 ~ 255 215 ~ 413
C >1000 177 ~ 346
T 62 ~ 232 216 ~ 378
S1 88 ~ 453 384 ~ 716
M 55 ~ 343 346 ~ 645
P1 65 ~ 348 387 ~ 614
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being ‘a’ and ‘b’ at both ends, the rate of epidermal regener-
ation were calculated by (a + b)/c for percentage wise
represention. No significant difference in re-epithelization
was observed between Medifoam® N and competitors’
products.
Figure 7 shows the blood vessel generation. Blood ves-
sels generated for recovery of impaired skin tissues were
marked with arrows, in confirmation of impaired skin tis-
sue regeneration. Compared to other dressings, angiogenic
effects of Medifoam®N on day 14 showed relatively higher
than treatment with gauze or ‘T’ product. In recovery of
wounds, angiogenic effect is one of the most important
factors, which is why Medifoam® N is expected to serve an
important role in healing wounds with its angiogenic
Fig. 2 Mean thickness (a) and density (b) of dressings
Fig. 3 Mean MVTR (a) and absorption/retention capacities (b) of dressing
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effect. Furthermore, impaired collagen deposition was ob-
served in evaluation of the epidermal connective tissues
composed (Fig. 8). Collagen deposition was stained with
Masson’s Trichrome Staining on Day 14, followed by
measurement of a total of three epidermal areas in con-
firmation of total recovery of skin tissues by way of colla-
gen deposition rate. All tested groups confirmed collagen
deposition with no significant differences, supporting the
usefulness of all investigated dressings.
Discussion
In this study, we compared Medifoam® N with other
commercially available polyurethane foam-based dress-
ings and these revealed a unique profile of Medifoam®
N. Above all, Medifoam® N, a dressing material for cut
surgical wounds, has the smallest pore (25 ~ 75 μm) and
cell (100 ~ 350 μm) sizes. The pore size of the wound
contact layer is essential to exclude fibroblast and kera-
tin, thus contributing to reduced secondary damage
upon dressing change [18]. Additionally, the cell size of
absorptive layer may influence absorption capacity for
exudate. Leakage of exudate may contaminate clothing
or furniture if not retained. These results indicate that
the smallest and uniform pore/cell sizes of Medifoam® N
can effectively exclude tissue formed and better absorb
exudation and maintain moist condition. Furthermore,
the smallest pore size of Medifoam®N may contribute
strong capillary action. In particular, as discussed above,
absorption/retention capacity is regarded as the most
important physical properties of dressing materials, i.e.
good absorption/retention properties enable to absorb
exudates effectively and contained within the dressing to
provide a sustained, moderately moist wound environ-
ment [13, 19]. Medifoam®N has the densest structure
among all the products tested, and demonstrated a re-
markable absorption capacity (1.25 g/cm2) and excellent
retention capacity (0.47 g/cm2). Practically, product L
and P showed almost similar absorption capacity as well
as Medifoam®N, i.e. they have relatively higher porosity
with homogeneous pore size. These properties must be
influenced to increase absorption capacity. However,
their porous structure in cross-section was relatively
loose compared to Medifoam®N and these properties
must be the reason for the lower retention capacity. For
example, surface porosity of product A1 was lower than
other product and, pores in cross-section were also large
and loose. Therefore, these properties must be induced
that product A1 has lower capacity both in absorption
and retention. Interestingly, product P1 showed rela-
tively lower apsortion capacity while its retention cap-
acity was similar to Medifoam®N. Since their MVTR
value was lower than other product except for product
L, it is likely that absorbed exudates were almost
retained in the matrix. For example, product C showed
second highest in MVTR value and this value must be
affected to absorption/retention capacity, i.e. absorption
capacity of product C was practically similar to product
P1 but its retention capacity was significantly smaller
Fig. 4 Mean tensile strength (a) and elongation (b) of dressings
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than product P1 or Medifoam®N. Furthermore, absorp-
tion capacity of product L was practically similar to
Medifoam®N but its retention capacity was less than half.
Thomas studied absorption and retention capacities of
various foam-film dressings, and he reported that foam-
film dressings have a wide variation in product perform-
ance with differences in retention capacities. This was
likely to be attributable in part to varying moisture per-
meabilities of the outer film layer [20]. In our study of
absorption patterns, Medifoam® N rapidly absorbed fluid
without substantial horizontal spread (Additional file 1)
while other product such as product A did not immedi-
ately absorb the solution and some of them was leaked
out. These results indicated that Medifoam® N has excel-
lent physical properties as a wound healing material.
Rapid vertical exudate absorption and retention may
help to minimize the risk of maceration of skin around
the wound periphery. This benefit is likely to be en-
hanced by Medifoam® N’s moderate MVTR, which sug-
gests an ability to allow for an optimized exudate
drainage through evaporation. These properties suggest
that Medifoam® N is highly suitable for use in wound
management, particularly in wounds with moderate to
high production of exudate.
The properties of Medifoam® N which encourage a
moist wound healing environment may help to reduce the
frequency of dressing changes, mitigating not only health-
care costs but also patient pain and inconvenience. How-
ever, one concern with infrequent dressing changes is the
potential for ingrowth of new tissue into the dressing over
time, which may result in shearing trauma with inevitable
body movement upon dressing removal.
Our animal study illustrated the tendency toward
dressing-wound adhesion with traditional gauze dressings.
Our study demonstrated Medifoam® N’s remarkably small
pore size (51.3 μm) and high pore size uniformity. This
has substantial clinical significance with regards to
wound-dressing adhesion, particularly when less frequent
Fig. 5 Visual comparison of wound healing using gauze, Medifoam®
N, dressing A and T
Fig. 6 Epidermal Staining (x100, Left photo). Epidermal Recovery Rate (right). Assuming the entire length of wound being ‘C’ and the epidermal recovery
rates being ‘a’ and ‘b’ at both ends, the rate of epidermal regeneration were calculated by [(a + b)/C]*100 to represent in percent. (Scale bar = 500 μm)
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dressing changes are necessary. A dressing with a small
enough pore size is able to exclude newly formed tissue
and keratin during the healing process, precluding tissue
ingrowth. An in vitro study conducted in three types of
cultured fibroblasts showed that, after 3 h of culture on a
substrate plane, the average new fibroblast length was
approximately 50 μm [18]. They reported that fibroblasts
grew in size in a nearly linear fashion to reach a peak
length of approximately 140 μm after 24 h. The small pore
size of Medifoam® N, and possibly also Dressing L, could
thus be expected to prevent the entry of fibroblasts into
the dressing material. Indeed, our animal study showed no
Fig. 7 Staining of blood vessels generated (x 200). *: p < 0.01. **: p < 0.05
Fig. 8 Collagen Deposition on the rat skin tissues. Rat skin was stained with Masson’s Trichrome Staining on Day 14 for collagen staining, followed by
measurement of a total of three epidermal areas in confirmation of total recovery of skin tissues by way of collagen deposition rate (x 200). (Scale bar = 200 μm)
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dressing adhesion with Medifoam® N or the other two
polyurethane foam dressings during wound healing. Con-
sistent with this finding, previous clinical studies of the
postoperative use of Medifoam® N have also demonstrated
no detachment of the re-epithelialized tissue layer upon
dressing removal after 24–48 h and again after Days 3, 6,
and 9 [21]. A recent animal study also suggested that pore
size of polyurethane foam dressing plays a crucial role in
wound healing [22]. Using polyurethane foam dressings
under negative pressure, the investigators confirmed that
pore size was positively associated with tissue ingrowth
into the dressing interface; compared with foams of small
diameter pore size, the extent of tissue ingrowth was 3.7-
fold higher with foams of medium pore size, and 5.6-fold
higher with foams of large pore size on day 7 of healing.
In addition, larger pore sizes resulted in greater wound de-
formation and thickness of granulation tissue formation
[22]. The potential for ingrowth of newly formed tissue at
the dressing-wound interface is thus a key consideration in
wound dressing selection – particularly when dressings
which promote a moist wound environment are used with
the intention of extending the period of time between
dressing changes.
Medifoam® N has mid-range levels of thickness and
tensile strength in our physical properties study, with ex-
cellent elongation properties as shown in Figs. 2 and 4,
suggesting a good balance of sturdiness and flexibility,
which is an important feature of dressing materials to
enhance biomechanical protection of the wound area [5,
14, 17]. In our animal study, no practical visual differ-
ences in wound healing rates and angiogenesis rate were
observed between Medifoam® N and either gauze, dress-
ing A, or dressing T (Fig. 6). The rate of angiogenesis is
strongly influenced by an initially hypoxic environment,
such as that provided by an occlusive dressing, and that
angiogenesis plays a key role in wound healing [23]. The
optimal wound healing environment facilitated by the
advanced core physical properties of Medifoam® N, dis-
cussed above, has been illustrated in other in vivo stud-
ies. For example, in another murine model, Medifoam®
N showed superior wound-closure and re-
epithelialization properties versus other polyurethane
foam dressings when applied to full-thickness wounds of
5 mm diameter [24]. The enhancement of the wound
healing process with Medifoam® N versus traditional
Vaseline gauze has also been demonstrated in clinical
studies [25]. Among 120 hospitalized burn patients who
had undergone skin graft surgery, those wounds to
which Medifoam® N were applied showed faster healing
times (P < 0.01), less wound pain (P < 0.01) and less scar
formation compared with those to which Vaseline gauze
was applied [25]. Taken together, the favorable perform-
ance of Medifoam® N across our in vitro and in vivo
studies with regard to the creation of an optimal wound
healing environment suggests it is a favorable choice for
wound treatment in the clinical setting, according to its
commercial indications. Our studies support other pre-
clinical and clinical studies that suggest excellent facilita-
tion of wound healing with this product and may
provide more insight to the clinical observations made
then [24, 25]. In fact, the clinical data collected in these
studies showed a bigger difference to other foams than
the rat study conducted by us.
Conclusion
We compared eleven commercially available polyureth-
ane foam dressings. The physicochemical testing pro-
vided insight into key differences of devices of the same
category. Among them, Medifoam® N has the smallest
pore and cell sizes with excellent uniformity. It also has
optimized physical properties such as thickness, density,
tensile strength, elongation, MVTR and adsorptivity.
Due to these characteristics, Medifoam® N showed excel-
lent absorption/retention capacity and fluid absorption
patterns. Furthermore, these also contributed wound
healing potential observed in our study and previously
[24, 25]. We found that Medifoam® N showed the best
results among the employed dressing samples.
Additional file
Additional file 1: The absorption pattern observed with Medifoam®N
and dressing A. (DOCX 1518 kb)
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